Jan 23 (Reuters) - Swedish Orphan Biovitrum:
* FDA ACCEPTS INVESTIGATIONAL NEW DRUG APPLICATION AND GRANTS FAST TRACK STATUS FOR SOBI003 FOR THE TREATMENT OF MPS IIIA
* SAYS ‍CLINICAL STUDY WITH SOBI003 IS EXPECTED TO START DURING 2018​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)
 